✨ Medicines Notices




NEW ZEALAND GAZETTE, No. 34 β€” 21 APRIL 2016

Product:
Infanrix-Hib vaccine
Component 1:
Active Ingredients:
Detoxified pertussis toxin 25mcg
Diphtheria toxoid, adsorbed 30IU
Pertactin 8mcg
Pertussis filamentous haemagglutinin 25mcg
Tetanus toxoid 40IU

Dosage Form:
Suspension for injection

Component 2:
Active Ingredient:
Haemophilus influenzae vaccine, tetanus toxoid conjugate 10mcg

Dosage Form:
Powder for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturers:
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
GlaxoSmithKline Biologicals SA, Wavre, Belgium
GlaxoSmithKline Manufacturing SpA, Parma, Italy
GlaxoSmithKline Biologicals (Saint-Amand-Les-Eaux), Saint-Amand-Les-Eaux, France

Product:
Infanrix-IPV+Hib
Component 1:
Active Ingredients:
Detoxified pertussis toxin 25mcg
Diphtheria toxoid, adsorbed 30IU
Pertactin 8mcg
Pertussis filamentous haemagglutinin 25mcg
Polio virus type 1 40DAgU
Polio virus type 2 8DAgU
Polio virus type 3 32DAgU
Tetanus toxoid, adsorbed 40IU

Dosage Form:
Suspension for injection

Component 2:
Active Ingredient:
Haemophilus influenzae vaccine, tetanus toxoid conjugate 10mcg

Dosage Form:
Powder for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturers:
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
GlaxoSmithKline Biologicals SA, Wavre, Belgium
GlaxoSmithKline Manufacturing SpA, Parma, Italy
GlaxoSmithKline Biologicals (Saint-Amand-Les-Eaux), Saint-Amand-Les-Eaux, France

Product:
Synflorix
Active Ingredients:
Pneumococcal Polysaccharide type 1 1mcg
Pneumococcal Polysaccharide type 14 1mcg
Pneumococcal Polysaccharide type 18C 3mcg
Pneumococcal Polysaccharide type 19F 3mcg
Pneumococcal Polysaccharide type 23F 1mcg
Pneumococcal Polysaccharide type 4 3mcg
Pneumococcal Polysaccharide type 5 1mcg
Pneumococcal Polysaccharide type 6B 1mcg
Pneumococcal Polysaccharide type 7F 1mcg
Pneumococcal Polysaccharide type 9V 1mcg

Dosage Form:
Suspension for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturers:
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
GlaxoSmithKline Biologicals (Saint-Amand-Les-Eaux), Saint-Amand-Les-Eaux, France

Dated this 15th day of April 2016.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2016-go2199

Acting District Court Judge Appointed

51



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 34





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of Infanrix-Hib Vaccine

πŸ₯ Health & Social Welfare
15 April 2016
Vaccine, Infanrix-Hib, Distribution, Medsafe, GlaxoSmithKline
  • Chris James, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to Distribution of Infanrix-IPV+Hib Vaccine

πŸ₯ Health & Social Welfare
15 April 2016
Vaccine, Infanrix-IPV+Hib, Distribution, Medsafe, GlaxoSmithKline
  • Chris James, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to Distribution of Synflorix Vaccine

πŸ₯ Health & Social Welfare
15 April 2016
Vaccine, Synflorix, Distribution, Medsafe, GlaxoSmithKline
  • Chris James, Acting Group Manager, Medsafe, Ministry of Health

βš–οΈ Acting District Court Judge Appointed

βš–οΈ Justice & Law Enforcement
Judge, Appointment, District Court